Literature DB >> 18436957

Molecular determinants of the aggregation behavior of alpha- and beta-synuclein.

Robert C Rivers1, Janet R Kumita, Gian Gaetano Tartaglia, Matthew M Dedmon, Amol Pawar, Michele Vendruscolo, Christopher M Dobson, John Christodoulou.   

Abstract

Alpha- and beta-synuclein are closely related proteins, the first of which is associated with deposits formed in neurodegenerative conditions such as Parkinson's disease while the second appears to have no relationship to any such disorders. The aggregation behavior of alpha- and beta-synuclein as well as a series of chimeric variants were compared by exploring the structural transitions that occur in the presence of a widely used lipid mimetic, sodium dodecyl sulfate (SDS). We found that the aggregation rates of all these protein variants are significantly enhanced by low concentrations of SDS. In particular, we inserted the 11-residue sequence of mainly hydrophobic residues from the non-amyloid-beta-component (NAC) region of alpha-synuclein into beta-synuclein and show that the fibril formation rate of this chimeric protein is only weakly altered from that of beta-synuclein. These intrinsic propensities to aggregate are rationalized to a very high degree of accuracy by analysis of the sequences in terms of their associated physicochemical properties. The results begin to reveal that the differences in behavior are primarily associated with a delicate balance between the positions of a range of charged and hydrophobic residues rather than the commonly assumed presence or absence of the highly aggregation-prone region of the NAC region of alpha-synuclein. This conclusion provides new insights into the role of alpha-synuclein in disease and into the factors that regulate the balance between solubility and aggregation of a natively unfolded protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436957      PMCID: PMC2327276          DOI: 10.1110/ps.073181508

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  63 in total

1.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

2.  Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein.

Authors:  Md Faiz Ahmad; Tangirala Ramakrishna; Bakthisaran Raman; Ch Mohan Rao
Journal:  J Mol Biol       Date:  2006-10-03       Impact factor: 5.469

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form.

Authors:  He-Jin Lee; Chan Choi; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

5.  Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs.

Authors:  A L Biere; S J Wood; J Wypych; S Steavenson; Y Jiang; D Anafi; F W Jacobsen; M A Jarosinski; G M Wu; J C Louis; F Martin; L O Narhi; M Citron
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Identification of two distinct synucleins from human brain.

Authors:  R Jakes; M G Spillantini; M Goedert
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

7.  A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins.

Authors:  Robert Bussell; David Eliezer
Journal:  J Mol Biol       Date:  2003-06-13       Impact factor: 5.469

Review 8.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

Authors:  D F Clayton; J M George
Journal:  Trends Neurosci       Date:  1998-06       Impact factor: 13.837

9.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Structural determinants of PLD2 inhibition by alpha-synuclein.

Authors:  Jacqueline E Payton; Richard J Perrin; Wendy S Woods; Julia M George
Journal:  J Mol Biol       Date:  2004-04-02       Impact factor: 5.469

View more
  40 in total

Review 1.  Folding and misfolding of alpha-synuclein on membranes.

Authors:  Igor Dikiy; David Eliezer
Journal:  Biochim Biophys Acta       Date:  2011-09-16

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

Authors:  Gina M Moriarty; Michael P Olson; Tamr B Atieh; Maria K Janowska; Sagar D Khare; Jean Baum
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

4.  αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction.

Authors:  Becket Greten-Harrison; Manuela Polydoro; Megumi Morimoto-Tomita; Ling Diao; Andrew M Williams; Esther H Nie; Sachin Makani; Ning Tian; Pablo E Castillo; Vladimir L Buchman; Sreeganga S Chandra
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Christopher M Dobson; Ad Bax
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

6.  Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.

Authors:  Kuen-Phon Wu; Daniel S Weinstock; Chitra Narayanan; Ronald M Levy; Jean Baum
Journal:  J Mol Biol       Date:  2009-07-01       Impact factor: 5.469

7.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

8.  Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation.

Authors:  Elisa A Waxman; Kristel L Emmer; Benoit I Giasson
Journal:  Biochem Biophys Res Commun       Date:  2009-12-21       Impact factor: 3.575

9.  Structure of an Intrinsically Disordered Stress Protein Alone and Bound to a Membrane Surface.

Authors:  John Atkinson; Matthew W Clarke; Josephine M Warnica; Kelly F Boddington; Steffen P Graether
Journal:  Biophys J       Date:  2016-08-09       Impact factor: 4.033

10.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.